Abstract
The novel bifunctional compounds L1 and L2 carrying cluster glucosides as ligands for brain targeting liposomes were synthesized. 2-phenyl-1,3-dioxan-5-ol (8) and tetra-antennary alcohol (13) were used as the core scaffold to attach cholesterol derivatives by a triethylene glycol chain, while their remaining branches were linked with two or three benzylglucosides, which would be debenzvlated later to produce di-antennary glucosides L1 and tri-antennary glucosides ligand L2. This design provided an effective entry for the synthesized bifunctional compounds to cross blood brain barrier (BBB).
Keywords: Brain target, cholesterylated glucosides, GLUT1 transporter, liposome ligand, synthesis, blood-brain barrier, Liposome-drug, glucose, bi-functional, water-organic
Letters in Organic Chemistry
Title:Synthesis of Multivalent Glucosides with High Affinity for GLUT1 Transporter
Volume: 9 Issue: 6
Author(s): Boyi Qu, Xun Li, Jianbo Wu, Xiaolong Li, Li Hai and Yong Wu
Affiliation:
Keywords: Brain target, cholesterylated glucosides, GLUT1 transporter, liposome ligand, synthesis, blood-brain barrier, Liposome-drug, glucose, bi-functional, water-organic
Abstract: The novel bifunctional compounds L1 and L2 carrying cluster glucosides as ligands for brain targeting liposomes were synthesized. 2-phenyl-1,3-dioxan-5-ol (8) and tetra-antennary alcohol (13) were used as the core scaffold to attach cholesterol derivatives by a triethylene glycol chain, while their remaining branches were linked with two or three benzylglucosides, which would be debenzvlated later to produce di-antennary glucosides L1 and tri-antennary glucosides ligand L2. This design provided an effective entry for the synthesized bifunctional compounds to cross blood brain barrier (BBB).
Export Options
About this article
Cite this article as:
Qu Boyi, Li Xun, Wu Jianbo, Li Xiaolong, Hai Li and Wu Yong, Synthesis of Multivalent Glucosides with High Affinity for GLUT1 Transporter, Letters in Organic Chemistry 2012; 9 (6) . https://dx.doi.org/10.2174/157017812801322390
DOI https://dx.doi.org/10.2174/157017812801322390 |
Print ISSN 1570-1786 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6255 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Addictions and Stress: Clues for Cocaine Pharmacotherapies
Current Pharmaceutical Design New Pharmacological Approaches in Infants with Hypoxic-Ischemic Encephalopathy
Current Pharmaceutical Design Dendritic Cell Immunotherapy for Malignant Gliomas
Reviews on Recent Clinical Trials The Role and Impact of SNPs in Pharmacogenomics and Personalized Medicine
Current Drug Metabolism Dynamic Expression of MicroRNAs (183, 135a, 125b, 128, 30c and 27a) in the Rat Pilocarpine Model and Temporal Lobe Epilepsy Patients
CNS & Neurological Disorders - Drug Targets Nanocarriers Made from Non-Ionic Surfactants or Natural Polymers for Pulmonary Drug Delivery
Current Pharmaceutical Design Probiotics as an Adjuvant Therapy in Major Depressive Disorder
Current Neuropharmacology Analytical Techniques for DNA Methylation – An Overview
Current Pharmaceutical Analysis Current Management of Chordoma
Current Drug Therapy Cognitive Consequences of a Sustained Monocyte Type 1 IFN Response in HIV-1 Infection
Current HIV Research Heavy Metal Toxicity in Humans and its Preventive and Control Measures
Current Nutrition & Food Science The Role of Nucleoside Transport in the Antineoplastic Activity of Purine Nucleoside Chemotherapeutic Agents
Current Cancer Therapy Reviews Catastrophic Antiphospholipid Syndrome - 20 Years Later
Current Rheumatology Reviews Improving Brain Drug Targeting Through Exploitation of The Nose-to- Brain Route: A Physiological and Pharmacokinetic Perspective
Current Drug Delivery Simultaneous Interruption of Signal Transduction and Cell Cycle Regulatory Pathways: Implications for New Approaches to the Treatment of Childhood Leukemias
Current Drug Targets Molecular Dissection of Renal Ischemia-Reperfusion: Oxidative Stress and Cellular Events
Current Medicinal Chemistry MicroRNA Involvement in the Pathogenesis of Neuroblastoma: Potential for MicroRNA Mediated Therapeutics
Current Pharmaceutical Design Withdrawal Notice: COVID-19: Outbreak to Global
Anti-Infective Agents Chemotherapy and Delivery in the Treatment of Primary Brain Tumors
Current Clinical Pharmacology Advances in Stem Cells Transplantation for the Therapy of Parkinson’s Disease
Current Stem Cell Research & Therapy